Through a comprehensive whole‐body metabolic and physiological assessment, we report greater insulin resistance assessed by OGTT in adults post‐severe COVID‐19 compared to controls, though whole‐body blood glucose control and fuel oxidation rates were comparable. The gene discussed is INS; the disease is COVID-19.